Innate Pharma S.A. IPHA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -0.91% | -68.81% | 0.07% | -42.90% | 8.66% |
| Total Receivables | -0.92% | -40.83% | 0.07% | 531.54% | 8.66% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -0.91% | -23.44% | 0.07% | 10.87% | 8.65% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -0.91% | -7.73% | 0.07% | 50.37% | 8.66% |
| Total Current Assets | -0.91% | -58.79% | 0.07% | -28.18% | 8.66% |
|
|
|||||
| Total Current Assets | -0.91% | -58.79% | 0.07% | -28.18% | 8.66% |
| Net Property, Plant & Equipment | -0.91% | -17.87% | 0.07% | -12.17% | 8.65% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.92% | -17.78% | 0.07% | -90.51% | 8.66% |
| Total Assets | -0.91% | -45.63% | 0.07% | -32.58% | 8.66% |
|
|
|||||
| Total Accounts Payable | -0.91% | -28.66% | 0.07% | 64.10% | 8.66% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.91% | 20.38% | 0.07% | -1.57% | 8.66% |
| Total Finance Division Other Current Liabilities | -0.91% | -19.81% | 0.07% | 27.68% | 8.66% |
| Total Other Current Liabilities | -0.91% | -19.81% | 0.07% | 27.68% | 8.66% |
| Total Current Liabilities | -0.91% | -11.96% | 0.07% | 24.43% | 8.66% |
|
|
|||||
| Total Current Liabilities | -0.91% | -11.96% | 0.07% | 24.43% | 8.66% |
| Long-Term Debt | -0.91% | -32.69% | 0.07% | -23.87% | 8.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.79% | -55.49% | 0.09% | -35.82% | 8.64% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -0.91% | -4.81% | 0.07% | -15.65% | 8.66% |
| Total Liabilities | -0.91% | -12.49% | 0.07% | -3.93% | 8.66% |
|
|
|||||
| Common Stock & APIC | -0.91% | -1.54% | 0.07% | 0.16% | 8.66% |
| Retained Earnings | 0.91% | -2.63% | -0.07% | -6.73% | -8.66% |
| Treasury Stock & Other | -0.91% | -24.03% | 0.08% | -6.45% | 8.66% |
| Total Common Equity | 0.91% | -83.28% | -0.07% | -521.53% | 8.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.91% | -83.28% | -0.07% | -521.53% | 8.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.91% | -83.28% | -0.07% | -521.53% | 8.65% |
|
|
|||||